About this trial
SarcBOP - An interdisciplinary and translational registry
SarcBOP aims to establish a database that integrates every aspect possibly relevant to sarcoma treatment and research. SarcBOP thus will not be limited to specific questions or patient groups, but instead will build a comprehensive database including clinical, pathologic, and radiologic information, multi-layered molecular data, and patient-reported outcomes, combined with a dedicated biobank for tissue samples and liquid biopsies. As the study integrates seamlessly with the clinical activities of the Heidelberg Sarcoma Center, the Molecular Diagnostics Program of NCT Heidelberg, including the NCT/DKTK MASTER Program, and with the NCT Trial Center, including the PMO Clinical Trials Program, SarcBOP will generate a comprehensive and continuously growing resource for clinicians, researchers, and, finally, patients.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Suspected or proven diagnosis of soft-tissue or bone sarcoma (STBS)
Age ≥12 years
Ability to understand nature and individual consequences of the registry
Written informed consent
Disqualifiers
None
Trial population
Patients with Soft-tissue and Bone Sarcoma
Trial design
Other
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
overall survival
The length of time from the date of diagnosis disease, that patients diagnosed with are still alive
overall survival
The length of time from the date of diagnosis disease, that patients diagnosed
Secondary outcomes
progression free survival
length of time during and after treatment, that a Patient lives with the disease without getting worse
Other outcomes
Core questionnaire QLQ-C30
Standardized Quality of Life Assessment, Higher values are better
Fatigue module QLQ-FA12
Standardized Quality of Fatigue, Higher values are worse
PHQ-4 (anxiety and depression)
Standardized Quality of anxiety and depression, Higher values are worse
FACT-cog (cognitive function)
Standardized Quality of cognitive function, Higher values are better
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Prof. Dr. Richard F Schlenk
Lead sponsor
University Hospital Heidelberg
Sponsor institution